COSTAS Acquires Atlas Nanotech to Enter the Global Nanomedicine Market

On July 24, VCBeat (WeChat ID: vcbeat) learned from foreign media reports that COSTAS Inc. had acquired Atlas Nanotech (hereinafter referred to as “Atlas”) through an all-stock transaction. This deal marks COSTAS’s formal entry into the multi-billion-dollar global nanomedicine market. The terms of the stock transaction agreement include the resignation of COSTAS’s existing management and board members, who will receive retirement compensation in the form of 12.66 million shares, while COSTAS will appoint new management and a new board of directors.

Atlas will receive 25 million shares of CSSI stock, subject to a lock-up agreement with phased issuance over two years. Atlas Nanotech is a high-tech nanotechnology R&D company based in Guadalajara, Mexico, specializing in the field of nanomedicine. The company develops and markets nanopharmaceuticals globally, dedicated to applying the latest breakthroughs in nanotechnology to the medical sector.

Currently, the company has developed three mature nanomedicine products, including a patented nano-treated gauze for treating diabetic ulcers and burn patients (Nanogasa.com). Nanogasa will enter the global market this year. Led by a highly qualified professional team, Atlas is currently developing seven new nanotechnology-based medical products.

COSTAS’s new board of directors and executive team, including executive board members from Atlas and its key management personnel, are as follows: Dr. Julio Cesar Riestra Rodriguez has been appointed as the new Chief Executive Officer. Dr. Riestra Rodriguez, founder of Atlas Nanotech, will oversee the research and development of the company’s medical nanotechnology products. Juan Riestra, founder and executive board member of Atlas, will serve as Chief Business Officer; he is also the CEO of AORI Brand Media Consulting.

COSTAS Inc. is dedicated to investing in early-stage cryptocurrency and digital currency projects. Headquartered in Las Vegas, Nevada, USA, COSTAS excels at integrating distributed asset technology with financial technology (FinTech). Distributed networks represent the latest frontier in internet-based investment markets, much like social media did a decade ago. COSTAS firmly believes that products based on distributed asset technology will become the next Facebook or Twitter. Currently, the U.S. FinTech market is valued at approximately $1.24 trillion.

Atlas Nanotech is one of the few companies worldwide dedicated to the development of nanotechnology. Its business model ensures high scalability for its products through the commercialization of its patents. Atlas Nanotech possesses a portfolio of products available for marketing and/or further development, spanning various industries such as healthcare and surgery.

(Compiled by: Xu Wenjuan)